Search Results

Filter
  • 1-1 of  1 results for ""Parkinson Disease therapy""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Metformin improves depressive-like behavior in experimental Parkinson's disease by inducing autophagy in the substantia nigra and hippocampus.

  • Authors : Mendonça IP; Laboratory of Ultrastructure, Aggeu Magalhães Institute (IAM), Oswaldo Cruz Foundation (FIOCRUZ), Recife, PE, Brazil. .; Postgraduate Program in Biological Sciences (PPGCB), Federal University of Pernambuco (UFPE), Recife, Brazil. .

Subjects: Metformin*/Metformin*/Metformin*/pharmacology ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/drug therapy ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/metabolism

  • Source: Inflammopharmacology [Inflammopharmacology] 2022 Oct; Vol. 30 (5), pp. 1705-1716. Date of Electronic Publication: 2022 Aug 06.Publisher: Birkhäuser Country of Publication: Switzerland NLM ID: 9112626 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-1 of  1 results for ""Parkinson Disease therapy""